For decades, neuroinflammation was considered a secondary response to Alzheimer's disease, the brain's reaction to the amyloid plaques and tau tangles already present. More recent evidence has substantially revised this understanding. Chronic neuroinflammation, driven by activated microglia producing pro-inflammatory cytokines, appears to be a primary driver of the disease rather than a passenger. Genetic studies identifying variants in microglial immune genes as major Alzheimer's risk factors have been particularly influential in this revision.
How Systemic Inflammation Reaches the Brain
The brain was traditionally considered an immunologically privileged organ, isolated from the peripheral immune system by the blood-brain barrier. This view has been revised. The blood-brain barrier becomes more permeable with ageing, obesity, hypertension, and chronic sleep deprivation. When it does, peripheral inflammatory signals including IL-6, TNF-alpha, and CRP can enter the brain and activate microglial cells, initiating the neuroinflammatory cascade. This means that chronic systemic inflammation from any source, poor gut health, metabolic dysfunction, sleep deprivation, or chronic stress, can initiate neuroinflammatory processes that contribute to cognitive decline.
The Dietary and Lifestyle Levers
- Diet quality: the Mediterranean and MIND diets consistently reduce circulating inflammatory markers; ultra-processed food raises them
- Exercise: both aerobic and resistance training reduce inflammatory cytokines and improve blood-brain barrier integrity
- Sleep: the glymphatic system clears pro-inflammatory waste during deep sleep; poor sleep both increases and impairs clearance of neuroinflammatory markers
- Gut health: dysbiosis increases intestinal permeability and systemic inflammation via the gut-brain axis
- Omega-3 fatty acids: EPA and DHA from oily fish reduce neuroinflammatory markers and support resolvin production, which actively resolves inflammation
Sources
- Heneka, M.T., et al. (2015). Neuroinflammation in Alzheimer's disease. The Lancet Neurology, 14(4), 388-405.
- Ransohoff, R.M. (2016). How neuroinflammation contributes to neurodegeneration. Science, 353(6301), 777-783.
- Bredesen, D.E., et al. (2018). Reversal of cognitive decline in Alzheimer's disease. Aging, 10(6), 1350-1362.